About the Authors
- Peter A. Sloane
-
Contributed equally to this work with: Peter A. Sloane, Suresh Shastry
Affiliation Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Suresh Shastry
-
Contributed equally to this work with: Peter A. Sloane, Suresh Shastry
Affiliation Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Andrew Wilhelm
-
Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Clifford Courville
-
Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Li Ping Tang
-
Affiliation Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Kyle Backer
-
Affiliation Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Elina Levin
-
Affiliation Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- S. Vamsee Raju
-
Affiliation Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Yao Li
-
Affiliation Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Marina Mazur
-
Affiliation Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Suzanne Byan-Parker
-
Affiliation Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- William Grizzle
-
Affiliation Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Eric J. Sorscher
-
Affiliations Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Mark T. Dransfield
-
Affiliations Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Steven M. Rowe
-
* E-mail: smrowe@uab.edu
Affiliations Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
Competing Interests
Dr. Rowe served as a consultant for Vertex Pharmaceuticals for the design of CF clinical trials and also served as site PI for CF Clinical Trials sponsored by Vertex Pharmaceuticals. Dr. Dransfield has served on COPD-related advisory boards for Forest, GlaxoSmithKline and Boehringer Ingelheim. Dr. Dransfield has served as site PI for contracted COPD clinical trials sponsored by GlaxoSmithKline and Boehringer Ingelheim. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: PAS EJS MTD SMR. Performed the experiments: PAS SS AW CC LPT KB EL SVR YL MM SBP WG MTD SMR. Analyzed the data: PAS SS CC EL SVR YL SBP WG EJS MTD SMR LPT. Wrote the paper: PAS MTD SMR. Supervised the project: MTD SMR.